Macular Degeneration (AMD) and Other Retinal Diseases Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Macular Degeneration (AMD) and Other Retinal Diseases Market size is expected to grow at an annual average CAGR of 5% during 2022-2028. Age-related macular degeneration (AMD) is an eye condition that can blur your central vision. It occurs when the macula is damaged by aging. The macula is the part of the eye that controls sharp, straight vision. The macula is part of the retina (the light-sensitive tissue at the back of the eye).AMD is a common condition. It is the leading cause of vision loss in the elderly. AMD doesn’t cause complete blindness, but loss of central vision can make it more difficult to see faces, read, drive, or do close-up tasks at home, such as cooking or repairing objects.AMD develops very slowly in some people and faster in others. If you have early AMD, you may not notice any loss of vision for a long time. That’s why it’s important to have regular eye exams to see if you have AMD.

The following segmentation are covered in this report:

By Application

• Hospital
• Clinic
• Other

By Type

• Macular Degeneration
• Diabetic Macular Edema
• Diabetic Retinopathy(DR)
• Retinal Vein Occlusion
• Wet Age-Related Macular Degeneration (wAMD)
• Dry Age-Related Macular Degeneration (dAMD)
• Other

Company Profile

• Regeneron Pharmaceuticals
• Bayer HealthCare
• Novartis
• Roche
• Kanghong Pharma
• Merck
• Allergan
• Santen Pharmaceutical
• GlaxoSmithKline Pharmaceuticals
• Pfizer
• Acucela
• Valent Pharmaceuticals
• IVERIC

Scope of the report

The research study analyses the Macular Degeneration (AMD) and Other Retinal Diseases Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Macular Degeneration (AMD) and Other Retinal Diseases Market Report

• What was the Macular Degeneration (AMD) and Other Retinal Diseases Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Macular Degeneration (AMD) and Other Retinal Diseases Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.